Mono Pharmacare Ltd

Mono Pharmacare Ltd

₹ 23.8 -0.42%
02 May - close price
About

Incorporated in 1994, Mono Pharmacare Ltd is in the business of distribution of Pharmaceutical items[1]

Key Points

Business Overview:[1]
MPL is a distributor and supplier of a wide array of pharmaceutical products and medicines. It offers
Health Care Products, Antibiotic medicines, Cough Cold Anti-Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid
& Antiemetic medicines, Cardiac – Diabetic medicines, and Cosmo care products.

  • Market Cap 42.0 Cr.
  • Current Price 23.8
  • High / Low 46.8 / 22.1
  • Stock P/E 14.6
  • Book Value 17.2
  • Dividend Yield 0.00 %
  • ROCE 12.3 %
  • ROE 11.8 %
  • Face Value 10.0

Pros

  • Debtor days have improved from 151 to 90.0 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Earnings include an other income of Rs.1.70 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Sep 2023 Mar 2024 Sep 2024
21.96 34.60 36.12 44.38
20.62 32.56 35.70 41.73
Operating Profit 1.34 2.04 0.42 2.65
OPM % 6.10% 5.90% 1.16% 5.97%
0.19 0.78 0.92 0.78
Interest 0.56 0.58 0.64 0.59
Depreciation 0.04 0.04 0.04 0.03
Profit before tax 0.93 2.20 0.66 2.81
Tax % 31.18% 15.00% 12.12% 18.15%
0.64 1.87 0.58 2.29
EPS in Rs 0.52 1.06 0.33 1.30
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 TTM
13.92 70.72 80.50
13.05 68.19 77.43
Operating Profit 0.87 2.53 3.07
OPM % 6.25% 3.58% 3.81%
0.20 1.69 1.70
Interest 0.38 1.28 1.23
Depreciation 0.02 0.08 0.07
Profit before tax 0.67 2.86 3.47
Tax % 19.40% 14.69%
0.54 2.44 2.87
EPS in Rs 0.44 1.38 1.63
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 42%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -48%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024 Sep 2024
Equity Capital 12.37 17.67 17.67
Reserves 1.03 10.44 12.73
12.51 13.27 17.89
3.15 4.02 11.75
Total Liabilities 29.06 45.40 60.04
0.19 0.14 0.20
CWIP 0.00 0.00 0.02
Investments 1.97 3.59 0.00
26.90 41.67 59.82
Total Assets 29.06 45.40 60.04

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024
-13.49 -10.32
-2.18 -1.66
15.90 12.00
Net Cash Flow 0.23 0.02

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Mar 2024
Debtor Days 211.87 90.01
Inventory Days 466.39 118.95
Days Payable 64.21 16.55
Cash Conversion Cycle 614.04 192.41
Working Capital Days 614.89 193.03
ROCE % 12.33%

Shareholding Pattern

Numbers in percentages

5 Recently
Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025
56.72% 56.72% 56.72% 56.72% 56.72%
43.28% 43.27% 43.28% 43.28% 43.28%
No. of Shareholders 621528418463478

Documents